Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2005
05/26/2005CA2546323A1 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
05/26/2005CA2545756A1 Antibodies against secretoryleukocyte protease inhibitor
05/26/2005CA2545755A1 Plasmid system for multigene expression
05/26/2005CA2545603A1 Neonatal fc receptor (fcrn)-binding polypeptide variants, dimeric fc binding proteins and methods related thereto
05/26/2005CA2545454A1 Adenocarcinoma specific antibody sam-6, and uses thereof
05/26/2005CA2545325A1 Compositions for reducing bacterial carriage and cns invasion and methods of using same
05/26/2005CA2545255A1 Interleukin-10 antibodies
05/26/2005CA2545187A1 Vegf receptor antagonists
05/26/2005CA2544598A1 Antibodies to cd44 glycoforms and uses thereof
05/26/2005CA2544308A1 Cytokine antagonist molecules
05/26/2005CA2543982A1 Antibodies that bind interleukin-4 receptor
05/26/2005CA2543926A1 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease
05/26/2005CA2543920A1 Il-18 binding proteins
05/26/2005CA2543631A1 Monkey immunoglobulin sequences
05/26/2005CA2530605A1 Pro104 antibody compositions and methods of use
05/26/2005CA2512657A1 Protein complex using immunoglobulin fragment and method for the preparation thereof
05/25/2005EP1533619A2 Specific markers for metabolic syndrome
05/25/2005EP1533617A1 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
05/25/2005EP1533616A1 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
05/25/2005EP1533370A1 Novel atypical pneumonia-causing virus
05/25/2005EP1533320A1 HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION
05/25/2005EP1533319A1 Method of detecting perilymphatic fistula
05/25/2005EP1532984A1 Use of anti CD44 antibodies for eradicating stem cells in acute myeloid leukemia
05/25/2005EP1532446A2 G-protein coupled receptor ligands and methods
05/25/2005EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532176A2 Cd200-receptor mediated modulation of bone development
05/25/2005EP1532175A1 Humanized antibody and process for preparing same
05/25/2005EP1532174A2 Anti-igf-i receptor antibody
05/25/2005EP1532167A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
05/25/2005EP1532165A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
05/25/2005EP1532162A2 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
05/25/2005EP1531864A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/25/2005EP1531863A2 Antibody-avidin fusion proteins as cytotoxic drugs
05/25/2005EP1531862A1 Stabilized liquid anti-rsv antibody formulations
05/25/2005EP1531848A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/25/2005EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1068530B1 Diagnostic for metastatic prostate cancer
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0981637B1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005EP0862461B1 Methods of treating established colitis using antibodies against il-12
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0755451B1 Materials and methods for management of hyperacute rejection in human xenotransplantation
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620501A Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620311A Therapeutic agent
05/25/2005CN1619312A Specific markers for metabolic syndrome
05/25/2005CN1618969A Mammalian sytokine-like polypeptide-10
05/25/2005CN1618965A New type Japanese blood fluxes dominant pesition antigen molecule
05/25/2005CN1618958A Human cholesteryl ester synthetase-2c and its coding sequence
05/25/2005CN1618957A Human cholesteryl ester synthetase-2b and its coding sequence
05/25/2005CN1618813A Human source antibody of antithyroid agent receptor mutual action protein
05/25/2005CN1618812A Human Source antibody for anti CD20 and epithelial cell adhesion molecule
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618810A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618809A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618808A Liver cancer related protein and its coding sedquence and use
05/25/2005CN1618807A 分泌蛋白及其编码序列和用途 Secreted proteins and their coding sequences and uses
05/25/2005CN1618806A Liver cancer inhibition factor and its coding sequence and use
05/25/2005CN1618805A Nerve system development related protein and its coding sequence and use
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203178C Multivalent antigen-binding proteins
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2005US6897292 For detecting a genetic abnormality, cancer
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897050 Desaturase genes and their use
05/24/2005US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters
05/24/2005US6896885 Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/24/2005US6896881 Administering a measles virus that has a nucleic acid sequence encoding a heterologous polypeptide upstream of a nucleic acid encoding a viral polypeptide, the heterolog is released from the cell, expressed anddetecting the amount
05/24/2005CA2123875C Hepatitis-c virus testing
05/24/2005CA2037607C Humanised antibodies
05/20/2005CA2487657A1 Specific markers for metabolic syndrome
05/19/2005WO2005045044A2 Use of fibroblast growth factor fragments
05/19/2005WO2005044998A2 Enhanced b cell cytotoxicity of cdim binding antibody
05/19/2005WO2005044996A2 Chimeric receptors with 4-1bb stimulatory signaling domain
05/19/2005WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
05/19/2005WO2005044861A1 Polysaccharides of helicobacter pylori
05/19/2005WO2005044859A2 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005WO2005044858A1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
05/19/2005WO2005044857A1 Humanized anti-cd47 antibody
05/19/2005WO2005044856A2 Removal of high molecular weight aggregates using hydroxyapatite chromatography
05/19/2005WO2005044855A2 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
05/19/2005WO2005044854A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/19/2005WO2005044853A2 Anti-vegf antibodies
05/19/2005WO2005044848A1 Neutralizable epitope of hgf and neutralizing antibody binding to the same
05/19/2005WO2005044847A1 Marker peptide for alzheimer’s disease
05/19/2005WO2005044846A1 Adrenomedullin 2 and use thereof
05/19/2005WO2005044840A2 Modulation of anergy and methods for isolating anergy-modulating compounds
05/19/2005WO2005044792A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
05/19/2005WO2005044307A2 Methods of therapy for b cell-related cancers
05/19/2005WO2005044306A2 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
1 ... 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 ... 1494